Full Transcript Introduction to Mystical Experiences 0:01 [music] Welcome to the trip lab kitchen table 0:05 conversations about integrative medicine and psychedelics. [music] 0:08 I'm your host and attending physician Dr. Mariela Wood. 0:14 Welcome back to another episode of the trip lab. Today we are jumping back into 0:18 psychedelics and specifically talking about mystical experiences and why 0:23 medicine is uncomfortable talking about them even though they do appear 0:26 regularly. We often focus on the neuroscience and clinical implications 0:31 in psychedelic research and for good reason. That is the point. But there is 0:35 an interesting phenomenon that continues to surface in the data even though it 0:39 isn't usually the primary object of the study. And that is mystical type 0:43 experiences that people report even in our tightly controlled research 0:47 settings. And of course outside of medicine we do hear about these 0:51 experiences all the time. But I think it's worth talking about this and 0:55 bringing these two worlds together. It is tricky because mystical experiences 1:00 don't currently fit neatly into our neuroscientific frameworks. We do 1:04 understand some of what's happening in the brain. And we'll definitely talk 1:07 about that in this episode, but these experiences don't map cleanly into 1:11 fixing a discrete pathophysiology. And because they do sit uncomfortably 1:15 close to religion, spirituality, and meaning, medicine has historically tried 1:20 to keep them at arms length. So today, we're not going to make a decision 1:25 whether these mystical experiences are metaphysically real. We're not endorsing 1:30 any belief systems, and we're not turning psychedelics into spiritual 1:33 shortcuts. We're going to ask a few different questions. 1:37 Why does medicine struggle to talk about these type of experiences that do appear 1:41 to matter so much clinically? What do people actually report during these 1:46 experiences? And what does the neuroscience tell us about why they 1:50 occur? We'll also look at strikingly similar experiences throughout history 1:54 long before we actually had a field of pharmarmacology 1:58 and what happens when medicine reflexively pathizes meaning instead of 2:02 learning how to work with it. Because whether or not medicine likes the
What Counts as a Mystical Experience 2:06 language, patients aren't just reporting symptom reduction. They're describing 2:11 changes in identity, perspective, and their relationship to the suffering. And 2:16 ignoring that, or at least pushing it to the side or not studying it as 2:20 rigorously just leaves us without a framework to understand it responsibly. 2:25 So today, we're going to jump into that a little bit. We're going to explore 2:28 mystical type experiences through multiple lens. Neuroscience, history, 2:32 clinical research, and medical culture itself. So, first of course, let's start 2:37 with what is a mystical experience? When researchers talk about mystical type 2:41 experiences, they're not using the term loosely or poetically. They actually are 2:46 referring to a fairly consistent cluster of subjective features that show up 2:50 across psychedelic studies, across cultures, and even across time. In fact, 2:54 we actually do have standardized tools to measure this. Most commonly, the 2:59 mystical experience questionnaire, which was originally inspired by the work of 3:02 William James. So, across these studies, people tend to report several core 3:07 elements. A sense of unity or interconnectedness, 3:12 often described as feeling merged with other people, nature, or the universe 3:16 itself. A transcendence of time and space, where 3:20 the usual sense of past, present, and future just goes away. A loss or 3:25 softening of the ego or the narrative of the self. A profound sense of meaning or 3:30 insight, sometimes described as knowetic, as if something deeply true 3:34 was understood rather than reasoned through. and often an element of 3:38 ineffibility, the sense that the experience is difficult or impossible to 3:41 fully put into words. What I think is striking is not just the 3:46 content of these experiences, but how similar they are, even when the 3:50 individual substances and settings are very different. Now, from a medical 3:54 perspective, this immediately raises questions. Are these experiences 3:59 hallucinations, delusions? 4:02 Are they simply just byproducts of altered neurochemistry? This is 4:06 important to note because in psychiatry a key distinction is not whether the 4:10 experience is unusual but whether it is disorganizing or integrating. 4:16 In clinical trials, mystical type experiences are typically associated 4:19 with greater psychological coherence, improved mood, reduced rigidity, and 4:24 improved functioning, not fragmentation or loss of reality. Which brings us to 4:30 the actual neuroscience. From what we understand so far, these experiences 4:34 tend to occur alongside specific reproducible brain regions. So, 4:38 decreased activity in the default mode network, which we've talked about a lot 4:41 on here, increased global connectivity between brain regions that don't 4:45 normally communicate as freely, and a loosening of the brain's predictive 4:49 filters. So, basically, the brain becomes less focused on maintaining a 4:53 tight self-reerential narrative and more open to novel associations, 4:58 perspectives, and meanings. But that doesn't tell us what the experience
Neuroscience of Ego Dissolution 5:01 means. And importantly, these experiences are not inherently mystical 5:06 because of the drug. They are mystical because of how the mind behaves when the 5:10 sense of self is altered. This is why similar descriptions appear in 5:14 meditation, fasting, sensory deprivation, near-death experiences, and 5:19 religious rituals long before we actually studied psychedelics in a lab. 5:24 So when we actually look at the neuroiming studies using functional MRI 5:27 and EEGs, we see a set of fairly reproducible brain level changes 5:32 associated with our classic psychedelics like psilocybin, LSD, and IASA. One of 5:37 the most consistent findings that I want to touch a little bit deeper on is that 5:41 reduced activity and connectivity in the default mode network. So this network is 5:45 heavily involved in what we call self-reerential thinking. So, our 5:49 internal narrative and what allows us to understand ourselves as a personal eye 5:53 over time. It's what allows us to position ourselves in a timeline and 5:57 reflect back to memories and think about ourselves in the future. And it's also 6:01 what allows us to have personal likes or dislikes and is thought to be the 6:05 physical network location of the Freudian ego. So, when you take a 6:10 psychedelic, the DMN quiets down. there's less activity happening and less 6:15 connectivity between it and other brain networks. When this happens, the brain 6:20 becomes less anchored to that ongoing story of self. Also, while this is 6:25 happening, we see increased global connectivity. So, brain regions that 6:28 don't normally communicate as freely begin exchanging information. The brain 6:33 becomes less hierarchical and more integrated. Some researchers describe 6:37 this as a temporary flattening of the brain's usual command structure. 6:42 Another important concept here is what we call neural entropy. Under 6:46 psychedelics, the brain appears to move into a more flexible and less 6:50 constrained state. So, prior beliefs, especially rigid or maladaptive ones, 6:55 seem to carry less weight and matter less because our focus on ourselves has 6:59 diminished temporarily. From a purely mechanistic standpoint, this helps 7:03 explain several core features of mystical experiences. Why the sense of 7:07 self can dissolve. Why time and space feel less linear, why new meanings and 7:13 insights feel suddenly accessible, and why experiences can feel deeply novel 7:17 yet profoundly familiar at the same time. But here's the critical limitation 7:22 of what we know about the neuroscience. It can describe correlates but not 7:27 conclusions. We can say that decreased DMN activity is associated with ego 7:31 dissolution. We can also say that increased connectivity correlates with 7:35 feelings of unity. What we can't say is whether the meaning people derive from 7:39 these experiences is true, symbolic, or purely constructed. Neuroscience is 7:45 simply not equipped to answer that question, at least at this time. And in 7:49 my opinion, it doesn't need to be right now. Medicine already accepts this 7:53 distinction in other domains. We don't invalidate grief because we can map it 7:57 to limbic activation. We don't dismiss love because oxytocin is involved. And 8:03 we don't deny pain simply because it lacks a clear structural lesion. 8:07 Similarly, identifying the neural mechanisms associated with mystical 8:11 experiences does not explain them away either. It just simply tells us how the 8:15 brain enters a stage where these experiences can reliably occur. And this 8:19 is where psychedelics become especially interesting. Not because they generate 8:23 something artificial or a quote unquote hallucination, but because they reveal a 8:28 latent capacity of the human mind. Like we said earlier, that same phenomenology 8:32 appears in deep meditation, fasting, prolonged prayer, sensory deprivation, 8:37 and near-death experiences. Psychedelics just offer a reproducible way to study 8:41 the state in real time. But let's pause on the neuroscience just for a second 8:45 here and take a little detour back in time. Because these experiences did not 8:50 just start now with what we're studying. They began many years ago and have been
Mystical States Across History and Religion 8:54 recorded throughout history and connected to many religions. Actually, 8:57 what I think is fascinating is that across time, language, and continents, 9:01 human beings described strikingly similar experiences. Even before there 9:06 was a shared scientific vocabulary, people described the same core features. 9:11 A dissolution of the ordinary sense of self, a feeling of unity or 9:14 interconnectedness, transcendence of time, and a deep sense of meaning that 9:19 felt known rather than reasoned. The metaphor has changed across these 9:23 stories. There's different gods in the different religions. The cosmologies 9:27 changed, but the experience itself remained surprisingly consistent, which 9:32 I think suggests that what we're seeing may not be the spread of a single belief 9:36 system, but a recurring human experience that different cultures learned to 9:40 interpret in different ways. And we don't just see this in the descriptions 9:43 of mystical states, but also in the religious narratives themselves. 9:48 Across traditions that developed independently, remarkably similar 9:52 stories emerge, suggesting a shared symbolic response to overwhelming 9:56 experience rather than a simple borrowing. 10:00 For example, we see the story of a great flood appearing in the Hebrew Bible with 10:04 Noah, in the epic of Gilgamesh, in the Hindu tradition of Manu. We also see 10:10 creation stories, death and rebirth motifs, divine encounters, and 10:14 revelations that repeat across cultures with different characters, but a similar 10:19 emotional and psychological contour. So, were these because of psychedelics? 10:23 Maybe, maybe not. But we are actually seeing some concrete examples of how 10:27 psychedelics may have played a role in these religious experiences. My personal 10:32 favorite brings us back to ancient Greece and the Ulysian mysteries. Many 10:36 people consider the first quote unquote religion. Initiates to this society, 10:41 religion, whatever you want to call it, including figures like Cicero and Marcus 10:45 Aurelius, participated in this ceremony, this initiation ceremony, and they were 10:50 sworn to secrecy. But what we do know after the ceremony, many reported losing 10:55 their fear of death and gaining a profound sense of meaning and continuity 10:59 afterwards. Scholars have long speculated that the 11:02 ceremonial drink that they drank during the ceremony may have contained urgot 11:07 contaminated barley and urgot is what LSD or acid was initially derived from. 11:13 So we think that they were actually drinking LSD infused wine. Next we have 11:19 a more well-known story. So this is Moses in the burning bush that comes 11:22 from the Bible. This comes from the book of Exodus. So Moses encounters this 11:26 burning bush and hears a voice that calls him by name, commands his 11:30 attention, and delivers messages that essentially change his his identity and 11:35 life's purpose. And some scholars have speculated that 11:38 this burning bush may not have been purely metaphorical. 11:42 One theory suggested the bush could have been a plant containing psychoactive 11:46 compounds such as the acacia species, which are native to the region and 11:51 contain DMT. So he may have been inhaling DMT to have this experience. 11:56 Then we have more welldocumented examples of psychedelics embedded 12:00 directly into religious life and these come from the Mesoamerican mushroom 12:03 traditions particularly among the Aztec Maya and likely other cultures. So we 12:09 actually have archaeological evidence and writing that all point to the 12:12 ceremonial use of psilocybin containing mushrooms in these religious rituals. 12:17 From these writings, we see that mushrooms were used in ceremonies in a 12:20 structured ritual context and they reported visions, encounters with 12:25 deities, moral instruction, prophecy, and deep emotional transformation. We 12:30 also see stone mushroom effiges dating back to more than 2,000 years, 12:34 suggesting that these practices were actually central to religious life. 12:38 Another example, a little bit more modern, is the ceremonial use of peyote 12:41 within the Native American church. So peyote is a cactus containing masculine 12:46 and has been used for thousands of years in indigenous spiritual practices across 12:50 North America. In the Native American church, peyote is 12:54 consumed during highly structured overnight ceremonies that also involve 12:58 prayer, music, communal support, and moral reflection. Participants often 13:02 describe visions, encounters with guiding presences, emotional catharsis, 13:07 ego dissolution, and enduring changes in perspective or behavior after the 13:11 experience. Okay, last I will end this little detour back through time to a 13:16 more recent study that I think is unbelievably fascinating. So, just this 13:20 past year, researchers at John's Hopkins and NYU invited around 30 religious 13:25 leaders, including priests, rabbis, pastors, and ministers from different 13:29 faith traditions to participate in a guided highdosese mushroom trip. They 13:35 wanted to explore the sacred and spiritual implications that psychedelics 13:38 could have on people whose lives already revolve around questions our meaning, 13:42 transcendence and the divine. So what they found and again the participants 13:47 were priests, rabbis and pastors. They described their psilocybin experience
Medicine, Psychiatry, and the Problem of Meaning 13:52 among one of the most spiritually significant experience of their lives 13:57 compared to and for some reporting exceeding the most meaningful moments 14:01 they've encountered through prayer, ritual, or years of religious practice. 14:05 What is also interesting is that the experiences seem to interact with each 14:09 religious leader's existing belief systems. So it did not disrupt their 14:13 faith, but instead it fostered greater openness, humility, and a less rigid 14:18 sense of how the sacred can be encountered. Some also described 14:21 insights and imagery that didn't fit neatly into their theological 14:24 frameworks, but noted that it still felt coherent, meaningful, and spiritually 14:29 authentic. So I personally think that this suggests that mystical type 14:33 experiences may be a core human capacity, one that psychedelics can 14:37 reliably evoke but do not exclusively define. And I think that makes them 14:42 worth taking seriously. So looking at all these examples from history to 14:46 current and peeking into the neuroscience that we mentioned in the 14:49 beginning, even seeing religious leaders being open to talking about 14:52 psychedelics, why are we still struggling in the medical community? Why 14:57 does medicine struggle so much with experiences that humans have 15:00 encountered, integrated, and interpreted for thousands of years? 15:04 I think part of the answer lies in the historical foundations of Western 15:08 medicine. So as medicine evolved into a more scientific discipline, it 15:13 intentionally separated itself from religion, mysticism, and metaphysical 15:17 explanations of illnesses. This separation was certainly necessary 15:21 at the time so they could develop rigorous methods, standardized 15:25 diagnostics, and reproducible treatments. But in doing so, it also 15:31 created a framework in which experiences that could not easily be observed, 15:34 measured, or falsified became increasingly suspect. Within this model, 15:39 subjective experience was tolerated primarily as data, something to be 15:43 reported, but not as a legitimate site of knowledge in its own right. So 15:48 meaning, belief, and interpretation were often relegated to the periphery, kind 15:53 of a secondary thing rather than interweaving it into our clinical 15:56 diagnostics. I think reductionism further reinforce this discomfort. 16:00 Modern medicine is trained to identify discrete mechanisms and causal pathways. 16:06 So a receptor, a lesion, a disregulated pathway that can be targeted and 16:11 corrected. And mystical experiences do not conform neatly into this approach. 16:17 They don't have a single brain region or follow predictable dose response curves 16:22 or resolve through suppression. Instead, they involve global changes in 16:26 perception, identity, and interpretation. I think there's also a 16:30 deeper cultural tension at play here, too. 16:33 Mystical experiences sit at the intersection of neuroscience, 16:36 psychology, spirituality, and philosophy. Domains that I think 16:40 medicine has historically tried to keep separate. So engaging with these 16:43 experiences raises concerns about the therapeutic boundaries, religious 16:47 neutrality, and scientific legitimacy. So in order to avoid all that or 16:52 overstepping professional roles, medicine has often responded by 16:56 minimizing or at least reframing these experiences side effects rather than the 17:00 central features of healing. Psychiatry in particular has had to navigate this 17:05 terrain very cautiously because many elements of mystical experiences, so 17:09 altered perception, auditory quote unquote hallucinations, 17:14 disillusion of the ordinary sense of self do overlap superficially with 17:18 symptoms seen in psychotic disorders like schizophrenia. So without careful 17:22 attention to context, intentionality and integration, it can be difficult to 17:27 distinguish experiences that are disorganizing like schizophrenia from 17:31 those that are deeply integrating. So as a result, psychiatry is often 17:36 defaulted to a protective stance prioritizing symptom containment over 17:41 interpretive engagement. I do want to bring us back though to the 17:45 early days of psychiatry when there was a genuine interest in the context of 17:49 psychotic experiences, not just their suppression. So Carl Jung in particular 17:54 spent years studying schizophrenia and psychosis across cultures. What struck 17:59 him was not simply the presence of delusions or hallucinations, but the 18:04 remarkable similarity in the stories that people told even across countries, 18:08 languages, or belief systems. Patients who had never met one another 18:13 and who came from entirely different cultural backgrounds described the same 18:18 symbols, themes, and narratives. So, you begin to wonder whether these 18:23 experiences were drawing from something deeper than individual pathology. This 18:27 is what he eventually later conceptualized as his archetypes and the
Prayer, Spirituality, and Clinical Outcomes 18:31 collective unconscious. What is even more fascinating is that 18:35 Jung didn't just study these states from the outside. He also documented periods 18:40 of his own life where he intentionally entered altered psychological states, 18:45 states that by modern standards might look uncomfortably close to psychosis. 18:50 He described vivid visions, encounters with these symbolic figures, and intense 18:55 inner experiences that he was able to move in and out of deliberately. 19:00 And that word deliberately is key here because by our modern definition, 19:04 schizophrenia is not a voluntary or controlled state. It is persistent, 19:09 disorganizing, and functionally impairing. Jung's experiences and the 19:14 mystical type experiences reported in psychedelic research do not meet this 19:18 criteria. They are timelmited, often coherent, and frequently followed by 19:23 increased insight, integration, and improved functioning. 19:27 So, psychedelic experiences are not schizophrenia, and schizophrenia is not 19:32 a mystical experience as far as we know so far. But the fact that they share 19:36 certain features, I think it's pretty interesting and worth taking seriously 19:40 because it suggests that what medicine is labeled as purely pathological in 19:44 some contexts may in others reflect a broader human capacity for altered 19:49 meaning making. So the difference I think is not just in the experience but 19:53 the duration of it, the context and how we can control it and integrate it. So 19:57 just a little sprinkle of maybe the overlap between psychedelics and 20:00 schizophrenia. again ending with psychedelics do not induce a 20:04 schizophrenic state. But we'll put that on pause for now and jump back into our 20:08 actual mystical experiences in modern medicine. So let's get back into the 20:13 data. Let's look at some actual studies that have been done around spiritual and 20:16 religious experiences in medicine. One of the earliest and most well-known 20:20 attempts to study spirituality in a biomedical framework comes from research 20:24 on intercessory prayer. These studies were designed to answer a 20:28 very specific question. Can prayer affect health outcomes even when 20:33 patients don't know they're being prayed for? In several of these trials, 20:37 patients were randomly assigned to receive remote prayer from strangers, 20:41 often in religious groups without any contact with the patient and without the 20:46 patients awareness. The idea was to eliminate any placebo 20:50 effects, expectation or changes in behavior. So essentially isolating 20:54 prayer as the intervention. Some early studies actually did show modest 20:58 benefits, particularly in cardiac care settings. They reported fewer 21:02 complications or better clinical course scores among patients who were prayed 21:06 for. But more studies were done, trials became larger, and the results did 21:10 become a little bit mixed. The most famous example is a large randomized 21:14 trial of patients undergoing coronary artery bypass surgery. This one did not 21:19 show that prayer itself improved outcomes when patients were unsure if 21:23 they were being prayed for. Interestingly though, and I think this 21:26 is often overlooked, the group that was told with certainty that they were being 21:30 prayed for actually had worse outcomes, which raises questions about 21:34 expectation, pressure, and anxiety rather than the actual prayer itself. I 21:38 think the key here is that these studies highlight that meaning, expectation, and 21:42 belief can influence physiology and outcomes in complex ways, sometimes 21:46 beneficially and sometimes not. Beyond prayer, there's a much larger 21:52 body of evidence looking at spirituality and religion as patient characteristics 21:55 rather than interventions. So, we have observational studies across 21:59 multiple populations that have repeatedly shown associations between 22:03 self-reported spiritual or religious beliefs and better outcomes in areas 22:08 like depression, substance use recovery, coping with chronic illness, and even 22:12 mortality. These findings aren't exactly 22:15 straightforward. We often see spirituality overlapping with social 22:19 support, community belonging, and health behaviors. But I think the associations 22:23 are consistent enough that we can't ignore them. I think more compelling 22:27 clinically are the studies where spirituality is integrating into care in 22:31 a way that aligns with the patients already existing belief system. So for 22:36 example, in psychotherapy research, spiritual or religious adapted CBT or 22:41 cognitive behavioral therapy has been shown to outperform standard approaches 22:44 for patients who already identify as religious or spiritual. And this brings
Psychedelic Therapy and Lasting Change 22:48 us back to the psychedelic research. In our psychedelic trials, mystical type or 22:53 spiritually significant experiences consistently correlate with better 22:57 outcomes. In studies looking at psilocybin for cancer related anxiety 23:02 and depression, participants frequently reported increase in spiritual 23:06 well-being, meaning and life satisfaction that persists for months. 23:10 And analyses from these trials suggested the intensity of the subjective or 23:14 mystical experience actually predicts the degree of sustained symptom 23:19 improvement. We also see similar patterns in psychedelic assisted smoking 23:23 sessation in other addiction studies where the depth of insight, perceived 23:27 meaning, and transformative experiences are closely linked to long-term behavior 23:32 change. So, if we're starting to see that these mystical type experiences 23:37 actually do impact the long-term effects of the psychedelics, 23:42 I think understanding this has practical implications for how psychedelic 23:46 treatments can be designed and delivered. And this doesn't mean that we 23:50 need to abandon our scientific rigor or even adopt a spiritual language in 23:55 medicine. But I think we do need to refine our clinical lens here because 23:59 subjective experience, especially if it does reliably predict outcomes, can be a 24:05 part of a therapeutic mechanism. Psychedelics don't force us to choose 24:09 between biology and meaning. They ask us to hold both at once. And when we do 24:13 that well, when we evaluate experiences based on their impact, integration, and 24:18 durability rather than how strange they are, we move closer to a model of care 24:23 that reflects how healing actually happens for many patients. But overall, 24:28 I think this is very interesting and I think it begs the question, if the mind 24:32 has capabilities we're only beginning to map and understand in clinical research, 24:38 what else are we missing about the mind? how it heals and how we understand our 24:42 places in the world. Thanks for listening to the trip lab. If 24:47 you liked this episode, please subscribe and share so we can get the conversation 24:52 started about integrative medicine and psychedelics to destigmatize it and 24:56 fully explore what this could mean in the 24:59 >> [music] 25:04 [music]
Comments